Gelteq (GELS) Notes Payables (2023 - 2025)

Gelteq's (GELS) quarterly Notes Payables came in at $2.7 million in Q2 2025, up 96.02% year-on-year from $1.4 million in Q2 2024, and up 221.84% quarter-over-quarter from $836530.8 in Q4 2024.

Gelteq (GELS) Notes Payables (2023 - 2025) Analysis & Trends

Gelteq's Notes Payables history runs 3 years deep, the most recent figure standing at $2.7 million for Q2 2025.

  • On a quarterly basis, Notes Payables rose 96.02% year-over-year to $2.7 million in Q2 2025; TTM through Jun 2025 was $2.7 million, a 96.02% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 96.02% from the prior year.
  • Notes Payables advanced to $2.7 million in Q2 2025 per GELS's latest filing, from $836530.8 in the prior quarter.
  • Across five years, Notes Payables topped out at $2.7 million in Q2 2025 and bottomed at $3399.3 in Q2 2023.
  • The 3-year median for Notes Payables is $1.1 million (2024), against an average of $1.2 million.
  • Across the five-year window, Notes Payables surged 40305.81% in 2024 and soared 96.02% in 2025, its largest moves.
  • Year by year, Notes Payables stood at $3399.3 in 2023, then jumped by 24509.05% to $836530.8 in 2024, then surged by 221.84% to $2.7 million in 2025.
  • Per Business Quant, the three latest GELS Notes Payables figures stand at $2.7 million (Q2 2025), $836530.8 (Q4 2024), and $1.4 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Gelteq 740.00 -47,821.64 -

Historic Data

Download Data
DateValue
Jun 30, 2025 2.69 Mn
Dec 31, 2024 836,530.82
Jun 30, 2024 1.37 Mn
Jun 30, 2023 3,399.28